Advertisement
Journal Home
Search for

Volume 90, Issue 4, Pages 252-261 (July 2010)


View previous. 6 of 8 View next.

Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis

Nancy D. Marinac, Sara C. Parísa, Viviana M. Vélezad, Carlos A. Rojasb, Mauricio Rojasa, Luis F. GarcíaaCorresponding Author Informationemail address

Received 24 February 2010; received in revised form 5 May 2010; accepted 20 May 2010. published online 01 July 2010.

Summary 

Regulatory T cells (Tregs) play an essential role in immune homeostasis. In infectious diseases Tregs may inhibit protective responses facilitating pathogen multiplication and dissemination, but they may also limit the inflammatory response diminishing tissue damage. Although there is experimental and clinical evidence that Tregs are induced during Mycobacterium tuberculosis infection, their role in the immunopathogenesis of tuberculosis is still not completely understood. In this study, the phenotype, frequency and activity of circulating Tregs in active and latent tuberculosis were evaluated. Phenotypic analysis showed that Tregs were CD4+CD25highFOXP3+CD45RO+CD127-. High levels of circulating Tregs were found in patients with active pulmonary tuberculosis, compared to individuals with latent infection. Treg activity was evaluated by ELISPOT by determining the effect of CD25+ cell depletion on the frequency of IFN-γ and IL-17 producing cells after in vitro stimulation with ESAT-6, CFP-10 and PPD. Treg depletion increased the frequency of IFN-γ producing cells, without affecting the frequency of IL-17 producing cells, in both active and latent tuberculosis, irrespective of the antigen used. Neutralization of IL-10 did not have any effect on the frequency of IFN-γ and IL-17 producing cells. Altogether, these results suggest that during active tuberculosis Tregs inhibit protective Th1 responses, but not the proinflammatory Th17 responses, facilitating mycobacterial replication and tissue damage.

a Grupo de Inmunología Celular e Inmunogenética, Centro de Investigaciones Médicas, Universidad de Antioquia, Medellín, Colombia

b Grupo de Epidemiología, Facultad de Salud Pública, Universidad de Antioquia, Medellín, Colombia

c NDM is recipient of a predoctoral scholarship from Colciencias, Bogotá, Colombia

d VMV is recipient of a “Joven Investigador” award from Vicerrectoría de Investigaciones, Universidad de Antioquia, Medellín, Colombia

Corresponding Author InformationCorresponding author. LFG. Grupo de Inmunología Celular e Inmunogenética, Sede de Investigación Universitaria, Cra 53 N° 61-30, Lab. 410, Medellín, Colombia. Tel.: +57 4 219 6446; fax: +57 4 219 6450.

PII: S1472-9792(10)00066-1

doi:10.1016/j.tube.2010.05.003


View previous. 6 of 8 View next.

Advertisement